Skip to main content
SpringerLink
Log in

Clonidine reverses baclofen-induced increases in noradrenaline turnover in rat brain

  • Original Articles
  • Published:
Neurochemical Research Aims and scope Submit manuscript

Abstract

The effect of baclofen and clonidine, both individually and in combination, on noradrenaline turnover was examined in several brain regions as well as in the spinal cord using the α-methyl-p-tyrosine depletion method. Baclofen (30–50 mg/kg) consistently increased the turnover of noradrenaline in the cortex, hippocampus and spinal cord and this effect was stereoselective for thel-isomer. Clonidine (0.1 mg/kg) decreased noradrenaline turnover in these regions and reversed the effect of baclofen. In the striatum, baclofen (50 mg/kg) decreased the turnover of dopamine in a stereoselective manner. Clonidine (0.1 mg/kg) did not alter dopamine turnover but potentiated the effect of baclofen. These results support behavioural data which suggests that baclofen interacts with central noradrenergic pathways. The nature of such interactions appears to be complex.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Andén, N. E. Corrodi, H., Fuxe, K., Hökfelt, B., Hökfelt, T., Rydin, C., andSvensson, T. 1970. Evidence for a central noradrenaline receptor stimulation by clonidine. Life Sciences 9:513–523.

    PubMed  Google Scholar 

  2. Andén, N. E., Grabowska, M., andStrömbom, U. 1976. Different alpha-adrenoreceptors in the central nervous system mediating biochemical and functional effects of clonidine and receptor binding agents. Naunyn-Schmiedeberg's Arch. Pharmacol. 292:43–52.

    Google Scholar 

  3. Andén, N. E., andWachtel, H. 1977. Biochemical effects of baclofen (β-parachlorophenyl-GABA) on the dopamine and noradrenaline in the rat brain. Acta Pharmacol. Toxicol. 40:310–320.

    Google Scholar 

  4. Bowery, N. G., 1982. Baclofen: 10 years on. Trends in Pharmacological Sciences 3:400–403.

    Google Scholar 

  5. Bowery, N. G., Hill, D. R., Hudson, A. L., Doble, A., Middlemiss, D. N., Shaw, J., andTurnbull, M. 1980. (−)-Baclofen decreases neurotransmitter release in the mammalian CNS by an action at a novel GABA receptor. Nature 283:92–94.

    PubMed  Google Scholar 

  6. Cedarbaum, J. J., andAghajanian, G. K. 1977. Catecholamine receptors on locus coeruleus neurons: Pharmacological characterization. Eur. J. Pharmacol. 44:375–386.

    PubMed  Google Scholar 

  7. Corrodi, H., andHanson, L. C. F. 1966. Central effects of an inhibitor of tyrosine hydroxylation. Psychopharmcologia 10:116–125.

    Google Scholar 

  8. Cutting, D. A., andJordan, C. C. 1975. Alternative approaches to analgesia: baclofen as a model compound. Br. J. Pharmacol. 54:171–179.

    PubMed  Google Scholar 

  9. Da Prada, M., andKeller, H. H. 1976. Baclofen and γ-hydroxybutyrate: similar effects on cerebral dopamine neurons. Life Sci. 19:1253–1264.

    PubMed  Google Scholar 

  10. De Langen, C. D. J., Hogenboom, F., andMulder, A. H. 1979. Presynaptic noradrenergic α-receptors and modulation of3H-noradrenaline release from rat brain synaptosomes. Eur. J. Pharmacol. 60:79–89.

    PubMed  Google Scholar 

  11. Fielding, S., Wilker, J., Hynes, M., Zewczak, M. S., Novick, W. J., andLal, H. 1978. A comparison of clonidine with morphine for antinociceptive and withdrawal actions. J. Pharmacol. Exp. Ther. 207:899–905.

    PubMed  Google Scholar 

  12. Fung, S. C., Swabrick, M. J., andFillenz, M. 1985. Effect of baclofen on in vitro noradrenaline release from rat hippocampus and cerebellum: an action at an α2. Neurochem. Int. 7:155–163.

    Google Scholar 

  13. Gianutsos, G., andMoore, K. E. 1978. Tolerance to the effects of baclofen and γ-butyrolactone on locomotor activity and dopaminergic neurons in the mouse. J. Pharmacol. Exp. Ther. 207:859–869.

    PubMed  Google Scholar 

  14. Glowinski, J., andIversen, L. L. 1966. Regional studies of catecholamines in the rat brain. I. The disposition of3H-noradrenaline,3H-dopamine and3H-dopa in various regions of the brain. J. Neurochem. 13:655–669.

    PubMed  Google Scholar 

  15. Guyenet, P. G., andAghajanian, G. K. 1979. ACh, substance P and met-enkephalin in the locus coeruleus: Pharmacological evidence for independent sites of action. Eur. J. Pharmacol. 53:319–328.

    PubMed  Google Scholar 

  16. Hill, D. R., andDolphin, A. C. 1984. Modulation of adenylate cyclase activity by GABAB receptors. Neuropharmacology 23:829–830.

    Google Scholar 

  17. Karbon, E. W., Duman, R. S., andEnna, S. J. 1984. GABAB receptors and norepinephrine-stimulated cAMP production in rat brain cortex. Brain Research 306:327–332.

    PubMed  Google Scholar 

  18. Kelly, P. H., andMoore, K. E. 1978. Dopamine concentrations in the rat brain following injections into the substantia nigra of baclofen, γ-aminobutyric acid, γ-hydroxybutyric acid, apomorphine and amphetamine. Neuropharmacology 17:169–174.

    PubMed  Google Scholar 

  19. Levy, R. A., andProudfit, H. K. 1977. The analgesic action of baclofen β-(4-p-chlorophenyl)-γ-aminobutyric acid. J. Pharmacol. Exp. Ther. 202:437–445.

    PubMed  Google Scholar 

  20. Loullis, C. C., Felten, D. L., andShea, P. A. 1979. HPLC determination of biogenic amines in discrete brain areas in food deprived rats. Pharmacol. Biochem. Behav. 11:89–93.

    PubMed  Google Scholar 

  21. Lorez, H. P., Kiss, D., Da Prada, M., andHaeusler, G. 1983. Effects of clonidine on the rate of noradrenaline turnover in discrete areas of the rat central nervous system. Nauyn-Schmiedeberg's Arch. Pharmacol. 323:307–314.

    Google Scholar 

  22. Olpe, H. R., Demieville, H., Baltzer, V., Bencze, W. L., Koella, W. P., Wolf, P., andHaas, H. L. 1978. The biological activity of d- and l-baclofen (lioresalR). Eur. J. Pharmacol. 52:133–136.

    PubMed  Google Scholar 

  23. Paalzow, G., andPaalzow, L. 1976. Clonidine antinociceptive activity: Effects of drugs influencing central monoaminergic and cholinergic mechanisms in the rat. Nauyn-Schmiedeberg's Arch. Pharmacol. 292:119–126.

    Google Scholar 

  24. Sawynok, J. 1983. Monoamines as mediators of the antinociceptive effect of baclofen. Naunyn-Schmiedeberg's Arch. Pharmacol. 323:54–57.

    Google Scholar 

  25. Sawynok, J., andDickson, C. 1985. Evidence for the involvement of descending noradrenergic pathways in the antinociceptive effect of baclofen. Brain Research 335:89–97.

    PubMed  Google Scholar 

  26. Sawynok, J., andDickson, C. 1985.D-Baclofen is an antagonist at baclofen receptors mediating antinociception in the spinal cord. Pharmacology 31:248–259.

    PubMed  Google Scholar 

  27. Scatton, B., Zivkovic, B., Dedek, J., Lloyd, K. G., Constantinidis, J., Tissot, R., andBartholini, G. 1982. γ-Aminobutyric acid (GABA) receptor stimulation. III. Effect of progabide (SL 76002) on norepinephrine, dopamine and 5-hydroxytryptamine turnover in rat brain areas. J. Pharmacol. Exp. Ther. 220:678–688.

    PubMed  Google Scholar 

  28. Smith, D. F., andVestergaard, P. 1979. The role of monoamines for the central effects of baclofen on behavior of rats. J. Neural. Trans. 46:215–223.

    Google Scholar 

  29. Spector, S., Sjoerdsma, A., andUndenfriend, S. 1965. Blockade of endogenous norepinephrine synthesis by α-methyl-tyrosine, an inhibitor of tyrosine hydroxylase. J. Pharmacol. Exp. Ther. 147:86–95.

    PubMed  Google Scholar 

  30. Starke, K., andMontel, H. 1973. Involvement of α-receptors in clonidine-induced inhibition of transmitter release from central monoamine neurons. Neuropharmacol. 12:1073–1080.

    Google Scholar 

  31. Steardo, L., andSawynok, J. 1985. Clonidine reverses methylxanthine-induced potentiation of baclofen antinociception. Pharmacol. Biochem. Behav. 22:905–907.

    PubMed  Google Scholar 

  32. Suzdak, P. D., andGianutsos, G. 1984. Differential coupling of GABA-A and GABA-B receptors to the noradrenergic system: implications for a GABA-ergic role in depression. Soc. Neurosci. Abstr. 10: p. 899.

    Google Scholar 

  33. Terrence, C. F., Sax, M., Fromm, G. H., Chang, C. H., andYoo, C. S. 1983. Effect of baclofen enantiomorphs on the spinal trigeminal nucleus and similarities of carbamazepine. Pharmacology 27:85–94.

    PubMed  Google Scholar 

  34. Waldmeier, P. C., andMaitre, L. 1976. On the relevance of preferential increases of mesolimbic vs. striatal dopamine turnover for the prediction of antipsychotic effects of psychotropic drugs. J. Neurochem. 27:589–597.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacology, Dalhousie University, B3H 4H7, Halifax, Nova Scotia, Canada

    J. Sawynok & A. Reid

Authors
  1. J. Sawynok
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Reid
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sawynok, J., Reid, A. Clonidine reverses baclofen-induced increases in noradrenaline turnover in rat brain. Neurochem Res 11, 723–731 (1986). https://doi.org/10.1007/BF00965340

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00965340

Keywords

Search

Navigation